MINK THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.12 USD | +14.31% |
|
+20.42% | +4.67% |
| 13/05 | Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures | MT |
| 13/05 | MiNK Therapeutics, Inc. announced that it expects to receive $5.8 million in funding | CI |
Chart calendar MiNK Therapeutics, Inc.
274d32299f760e1697e7088.1sSgVtkeybkbfm_V0NZIDgeeaKtWDZqU303kUA-yqlA.oZP4MLAm-uFqDSWQuLguR0r5Pc84VPXAmyKjIn3F-zivotgs4EGq8HNPGA~3038936811c9b27cb19062605974b578
Upcoming events on MiNK Therapeutics, Inc.
Past events on MiNK Therapeutics, Inc.
| Today 06:00 pm | Q1 2024 Earnings Call |
| Today | Q1 2024 Earnings Release Pre-market |
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract Number: 1331 |
| 21/03/2024 06:00 pm | Q4 2023 Earnings Call |
| 21/03/2024 04:30 pm | Q4 2023 Earnings Release |
| 09/11/2023 07:00 pm | Q3 2023 Earnings Call |
| 09/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 01/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 735 |
| 14/09/2023 12:00 am | H.C. Wainwright Global Investment Conference - Fireside Chat |
| 12/09/2023 09:45 pm | Baird Global Healthcare Conference - Fireside Chat |
| 10/08/2023 05:00 pm | Q2 2023 Earnings Release |
| 08/08/2023 09:00 pm | BTIG Virtual Biotechnology Conference |
| 13/06/2023 08:00 pm | Annual General Meeting |
| 21/05/2023 | American Thoracic Society International Conference - Abstract Number : 10725 |
| 19/05/2023 09:30 pm | American Society of Gene Cell Therapy Meeting - Abstract No: 1488 |
| 11/05/2023 06:00 pm | Q1 2023 Earnings Call |
| 11/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 20/04/2023 07:30 pm | Investor Meeting - Key Opinion Leader |
| 18/04/2023 11:00 pm | American Association for Cancer Research Meeting - Abstract Number: CT275 |
| 21/03/2023 06:00 pm | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -28,4 -32,9 13.84% | -30,9 -31,4 1.48% | -22,9 -23,0 0.14% | -22,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -22,5 -22,3 -0.7% | -19,1 |
|
Net income Million USD | Released Forecast Spread | -16,2 | 0,00 0,00 - | -28,0 -32,0 12.45% | -22,5 -24,8 9.36% | -19,1 |
|
EPS USD | Released Forecast Spread | -1,87 | 0,00 0,00 - | -0,83 -0,89 6.74% | -0,65 -0,66 2.01% | -0,52 |
| Announcement Date | 14/09/21 | 18/03/22 | 21/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,36 -10,9 41.72% | -7,37 -7,37 -0% | -7,70 -7,56 -1.83% | -7,99 -8,23 2.98% | -7,89 -8,35 5.57% | -5,85 -8,17 28.37% | -6,34 -6,59 3.8% | -5,22 -6,48 19.45% | -5,50 -5,37 -2.5% | -3,83 -5,40 29.13% | -5,07 | -5,59 | -5,95 | -6,77 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,69 -8,09 29.71% | -6,20 -6,21 0.15% | -5,12 -6,08 15.86% | -5,46 -5,30 -2.92% | -3,81 -5,07 24.72% | -4,27 | -4,75 | -4,98 | -6,73 | |||||
|
Net income Million USD | Released Forecast Spread | -7,77 -8,91 12.81% | -5,69 -8,19 30.54% | -6,20 -6,55 5.37% | -5,12 -6,67 23.26% | -5,46 -5,30 -2.92% | -3,81 -5,07 24.72% | -4,27 | -4,75 | -4,98 | -6,80 | ||||
|
EPS USD | Released Forecast Spread | -0,23 -0,21 -9.52% | -0,17 -0,24 29.17% | -0,18 -0,19 6.89% | -0,15 -0,17 13.46% | -0,15 -0,15 0% | -0,11 -0,15 24.14% | -0,12 | -0,13 | -0,13 | -0,14 | ||||
| Announcement Date | 18/03/22 | 13/05/22 | 09/08/22 | 03/11/22 | 21/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 21/03/24 | 14/05/24 | - | - | - | - |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 16/05/2024 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 21/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 22/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for MiNK Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INKT Stock
- Calendar MiNK Therapeutics, Inc.
